Related Experiment Video
Updated: Nov 26, 2025

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Myocardial Infarction in Systemic Lupus Erythematosus - the Sex-Specific Risk Profile
Marija Vavlukis1, Daniela Pop-Gjorcevab2, Lidija Poposka1
1University Clinic for Cardiology, Medical Faculty, Ss' Cyril and Methodius University, Skopje, North Macedonia.
Insights
Systemic lupus erythematosus (SLE) significantly increases myocardial infarction risk through various mechanisms. Despite being a "female" disease, men with SLE face higher cardiovascular risks and poorer outcomes, necessitating tailored therapeutic considerations.
Area of Science:
- Cardiovascular Medicine
- Rheumatology
- Immunology
Background:
- Accelerated atherosclerosis is a common complication in patients with systemic lupus erythematosus (SLE).
- Inflammation and infection in SLE trigger molecular mechanisms leading to early endothelial dysfunction and atherosclerosis.
- The interplay of traditional cardiovascular risk factors and SLE-specific characteristics exacerbates atherosclerosis development.
Purpose of the Study:
- To analyze the relationship between systemic lupus erythematosus (SLE) and cardiovascular diseases.
- To emphasize the connection between SLE and acute myocardial infarction (MI).
Main Methods:
- A comprehensive literature review was conducted using PubMed and Cochrane databases.
- Keywords included SLE, atherosclerosis, atherothrombosis, coronary artery disease, myocardial infarction, prognosis, and sex specifics.
Main Results:
- Myocardial infarction (MI) rates in SLE patients are 2- to 10-fold higher than in the general population.
- Young women exhibit the highest relative risk for MI, while men have a 3-fold higher risk compared to women.
- Coronary artery involvement in SLE ranges from normal artery with thrombosis to vasculitis and atherosclerosis, with varied clinical presentations based on gender and age.
Conclusions:
- Systemic lupus erythematosus (SLE) is a significant contributor to both atherosclerotic and non-atherosclerotic mechanisms of myocardial infarction (MI).
- Therapeutic strategies for MI in SLE patients must consider these underlying mechanisms.
- Despite SLE being more prevalent in women, men with the disease experience increased cardiovascular risk and worse outcomes.
Background:
Accelerated atherosclerosis is widely present in patients with systemic lupus erythematosus.
Objective:
The aim of this review was to analyze the relationship between systemic lupus erythematosus and cardiovascular diseases, with the emphasis on acute myocardial infarction.
Methods:
We conducted a literature review through PubMed and Cochrane, using keywords: SLE, atherosclerosis, atherothrombosis, coronary artery disease, myocardial infarction, prognosis, sex specifics.
Results:
Various molecular mechanisms triggered by infection/inflammation are responsible for endothelial dysfunction and the development of atherosclerosis at an earlier age. A contributing factor is the cumulative effect of traditional cardiovascular risk factors interaction with disease-related characteristics. Myocardial infarction rates are 2- to 10-fold higher compared to the general population. Young women have the highest relative risk, however, men carry at least 3-fold higher risk than women. Coronary involvement varies from normal coronary artery with thrombosis, coronary microartery vasculitis, coronary arteritis, and coronary atherosclerosis. Typical clinical presentation is observed in men and older women, while atypical is more frequent in young women. Treatment is guided by the underlying mechanism, engaging invasive procedures alone, or accompanied with immunosuppressive and/or anti-inflammatory therapy. There are significant gender differences in pathophysiology and clinical presentation. However, they receive the same therapeutic treatments.
Conclusion:
Systemic lupus erythematosus is a major contributor to atherosclerotic and non-atherosclerotic mechanisms involved in the development of myocardial infarction, which should be taken into account during therapeutic treatment. Although systemic lupus erythematosus per se is a "female" disease, males are at increased cardiovascular risk and worse outcomes.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Coronary Artery Disease I: Introduction

